Our results revealed that in samples with higher counts of EpCAM+ tumor cells, the expression of HLA-G, ILT-2, ILT-4, and PD-L1 was significantly related to distant lymph node metastasis, advanced disease stage, and shorter patient survival. This evidence concerns the gene LILRB2 and metastatic malignant neoplasm in the lymph nodes.